The aim of the study was to determine the fluctuation of four markers expression: CD66c, CD304, CD86 and CD72 on leukemic blasts in pediatric patients with BCP-ALL, by comparing the expression levels of above mentioned antigens at day 15 and 33 of induction treatment and the diagnosis (day 0). This evidence concerns the gene CD86 and acute lymphoblastic leukemia.